期刊
CELLULAR & MOLECULAR IMMUNOLOGY
卷 5, 期 3, 页码 171-182出版社
CHINESE SOC IMMUNOLOGY
DOI: 10.1038/cmi.2008.21
关键词
MHC-I; TCR; MHC-I/TCR interaction; immune therapy
类别
Adoptive immunotherapy involving the transfer of autologous tumor or virus-reactive T lymphocytes has been demonstrated to be effective. in the eradication of cancer and virally infected cells. Identification of MHC-restricted antigens and progress in generation of adaptive immune responses have provided new direction for such treatment for severe pathologies such as cancer and autoimmune diseases. Here we review the latest development about the molecular basis of MHC-I/TCR interaction, and it's manipulation including enhanced MHC-I expression, modification of peptide and engineered TCR for clinical applications such as vaccine design, tumor therapy and autoimmune diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据